BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19360308)

  • 1. Usefulness of hexamethylenetetramine in combination with chemotherapy using free and pegylated liposomal doxorubicin in vivo, referring to the effect on quiescent cells.
    Masunaga S; Kono K; Nakamura J; Tano K; Yoshida H; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Liu Y; Ono K
    Oncol Rep; 2009 May; 21(5):1307-12. PubMed ID: 19360308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
    Masunaga S; Tano K; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K; Nakamura J
    Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status.
    Masunaga S; Tano K; Nakamura J; Watanabe M; Kashino G; Takahashi A; Tanaka H; Suzuki M; Ohnishi K; Kinashi Y; Liu Y; Ohnishi T; Ono K
    J Radiat Res; 2010; 51(1):27-35. PubMed ID: 19801892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effect of mild temperature hyperthermia combined with hexamethylenetetramine compared to its effect combined with tirapazamine in the treatment of solid tumors.
    Masunaga SI; Tano K; Nakamura J; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K
    Exp Ther Med; 2010 Jan; 1(1):169-174. PubMed ID: 23136610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
    Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Nishimura Y; Kinashi Y; Takagaki M; Hori H; Nagasawa H; Uto Y; Tsuchiya I; Sadahiro S; Murayama C
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1063-72. PubMed ID: 11429234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Akuta K; Takagaki M; Suzuki M; Kinashi Y; Abe M
    J Cancer Res Clin Oncol; 1996; 122(9):533-40. PubMed ID: 8781567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.
    Tuscano JM; Martin SM; Ma Y; Zamboni W; O'Donnell RT
    Clin Cancer Res; 2010 May; 16(10):2760-8. PubMed ID: 20460479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.
    Teymouri M; Farzaneh H; Badiee A; Golmohammadzadeh S; Sadri K; Jaafari MR
    Eur J Pharm Sci; 2015 Dec; 80():66-73. PubMed ID: 26299343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M
    Jpn J Cancer Res; 1997 Aug; 88(8):770-7. PubMed ID: 9330609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
    Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
    Masunaga S; Sakurai Y; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Nagasawa H; Uto Y; Hori H; Ono K
    Br J Radiol; 2006 Dec; 79(948):991-8. PubMed ID: 16916808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
    Yahuafai J; Asai T; Oku N; Siripong P
    Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asiatic acid enhances intratumor delivery and the antitumor effect of pegylated liposomal doxorubicin by reducing tumor-stroma collagen.
    Fang L; Kong SS; Zhong LK; Wang CM; Liu YJ; Ding HY; Sun J; Zhang YW; Li FZ; Huang P
    Acta Pharmacol Sin; 2019 Apr; 40(4):539-545. PubMed ID: 29921887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.